BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 18802168)

  • 1. Non-Hodgkin's lymphoma in patients with glioma treated with temozolomide.
    Neyns B; Cordera S; Joosens E; Pouratian N
    J Clin Oncol; 2008 Sep; 26(27):4518-9. PubMed ID: 18802168
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-Hodgkin lymphoma following temozolomide.
    Sharma A; Gupta D; Mohanti BK; Thulkar S; Dwary A; Goyal S; Muzumder S; Das P
    Pediatr Blood Cancer; 2009 Oct; 53(4):661-2. PubMed ID: 19533661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-Hodgkin's lymphoma in a patient on treatment with temozolomide.
    Otty Z; Sabesan S
    Asia Pac J Clin Oncol; 2012 Dec; 8(4):e53-4. PubMed ID: 22897453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Temodal--an alkylating cytostatic agent. Effectiveness in patients with malignant gliomas].
    Matsko MV
    Vopr Onkol; 2012; 58(3):425-8. PubMed ID: 22888663
    [No Abstract]   [Full Text] [Related]  

  • 5. Is protracted low-dose temozolomide feasible in glioma patients?
    Tosoni A; Cavallo G; Ermani M; Scopece L; Franceschi E; Ghimenton C; Gardiman M; Pasetto L; Blatt V; Brandes AA
    Neurology; 2006 Feb; 66(3):427-9. PubMed ID: 16476947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Central nervous system glioma. Multi-drug chemotherapy including temozolomide].
    Wakabayashi T
    Gan To Kagaku Ryoho; 2009 Jun; 36(6):938-40. PubMed ID: 19579330
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase I trial of temozolomide using an extended continuous oral schedule.
    Brock CS; Newlands ES; Wedge SR; Bower M; Evans H; Colquhoun I; Roddie M; Glaser M; Brampton MH; Rustin GJ
    Cancer Res; 1998 Oct; 58(19):4363-7. PubMed ID: 9766665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Low grade non-Hodgkin's lymphoma after combined therapy for Hodgkin's disease].
    Raya Sánchez JM; González Brito G; Hernández Nieto L; Brito Barroso ML; Alvarez Argüelles H; Jorge Hernández JA; Martín Herrera A
    Sangre (Barc); 1994 Dec; 39(6):461-4. PubMed ID: 7855699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium Trial.
    Chang SM; Prados MD; Yung WK; Fine H; Junck L; Greenberg H; Robins HI; Mehta M; Fink KL; Jaeckle KA; Kuhn J; Hess K; Schold C
    Cancer; 2004 Apr; 100(8):1712-6. PubMed ID: 15073861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary non-Hodgkin lymphoma of the ethmoid sinus after temozolomide.
    Broes K; Van Ginderachter L; Joosens E; Maes A; Theunissen K; Schepers S; Deben K; Claes J; Mebis J; Cox T
    B-ENT; 2015; 11(1):73-6. PubMed ID: 26513952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is protracted low-dose temozolomide feasible in glioma patients?
    Wong ET
    Neurology; 2006 Aug; 67(3):543-4; author reply 543-4. PubMed ID: 16894133
    [No Abstract]   [Full Text] [Related]  

  • 12. Possible leukemogenic potential of temozolomide.
    Weiss B; Geiger H; Davies SM
    Pediatr Blood Cancer; 2009 Apr; 52(4):553. PubMed ID: 19058212
    [No Abstract]   [Full Text] [Related]  

  • 13. [Recent advances in the medical treatment of glioma-temozolomide].
    Nishikawa R
    No To Shinkei; 2006 Dec; 58(12):1035-41. PubMed ID: 17193953
    [No Abstract]   [Full Text] [Related]  

  • 14. [Problems of chemotherapy for glioma].
    Hirose Y
    Gan To Kagaku Ryoho; 2011 Jun; 38(6):923-6. PubMed ID: 21751527
    [No Abstract]   [Full Text] [Related]  

  • 15. Temozolomide: a novel oral alkylating agent.
    Danson SJ; Middleton MR
    Expert Rev Anticancer Ther; 2001 Jun; 1(1):13-9. PubMed ID: 12113120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute lymphoblastic leukemia after temozolomide treatment for anaplastic astrocytoma in a child with a germline TP53 mutation.
    Momota H; Narita Y; Miyakita Y; Hosono A; Makimoto A; Shibui S
    Pediatr Blood Cancer; 2010 Sep; 55(3):577-9. PubMed ID: 20658636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temozolomide chemotherapy in patients with recurrent malignant gliomas.
    Yang SH; Kim MK; Lee TK; Lee KS; Jeun SS; Park CK; Kang JK; Kim MC; Hong YK
    J Korean Med Sci; 2006 Aug; 21(4):739-44. PubMed ID: 16891823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients receiving standard-dose temozolomide therapy are at risk of Pneumocystis carinii pneumonia.
    Yu SK; Chalmers AJ
    Clin Oncol (R Coll Radiol); 2007 Oct; 19(8):631-2. PubMed ID: 17644327
    [No Abstract]   [Full Text] [Related]  

  • 19. Rapid desensitization with temozolomide in patients with delayed maculopapular rash.
    Alonso-Llamazares A; Vega-Castro A; Beitia-Mazuecos JM; Mateo-Borrega B; Cardenas-Contreras R
    J Investig Allergol Clin Immunol; 2012; 22(6):448-9. PubMed ID: 23101195
    [No Abstract]   [Full Text] [Related]  

  • 20. An Australian experience with temozolomide for the treatment of recurrent high grade gliomas.
    Harris MT; Rosenthal MA; Ashley DL; Cher L
    J Clin Neurosci; 2001 Jul; 8(4):325-7. PubMed ID: 11437571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.